Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Nieuwlaat, W.A."'
Autor:
Sadik, Z.H.A., Voormolen, E.H.J., Depauw, P.R.A.M., Burhani, B., Nieuwlaat, W.A., Verheul, J., Leenstra, S., Fleischeuer, R., Hanssens, P.E.J.
Publikováno v:
In World Neurosurgery April 2017 100:361-368
Autor:
Nieuwlaat, W.A., Hermus, A.R.M.M., Ross, H.A., Buijs, W.C.A.M., Edelbroek, M., Bus, J.W., Corstens, F.H.M., Huysmans, D.A.K.C.
Publikováno v:
The Journal of Nuclear Medicine (1978), 45, 4, pp. 626-33
The Journal of Nuclear Medicine (1978), 45, 626-33
The Journal of Nuclear Medicine (1978), 45, 626-33
Contains fulltext : 57827.pdf (Publisher’s version ) (Closed access) A single, low dose of recombinant human thyroid-stimulating hormone (rhTSH) doubles 24-h RAIU and causes a more homogeneous distribution of radioiodine on thyroid scintigrams of p
Autor:
Nieuwlaat, W.A., Huysmans, D.A.K.C., Bosch, H. van den, Sweep, C.G.J., Ross, H.A., Corstens, F.H.M., Hermus, A.R.M.M.
Publikováno v:
Journal of Clinical Endocrinology and Metabolism, 88, 7, pp. 3121-9
Journal of Clinical Endocrinology and Metabolism, 88, 3121-9
Journal of Clinical Endocrinology and Metabolism, 88, 3121-9
Item does not contain fulltext In patients with nodular goiter, radioiodine ((131)I) therapy results in a mean reduction in thyroid volume (TV) of approximately 40% after 1 yr. We have demonstrated that pretreatment with a single, low dose of recombi
Autor:
Kokshoorn, N.E., Smit, J.W.A., Nieuwlaat, W.A., Biermasz, N.R., Bisschop, P.H., Veldman, R.G., Roelfsema, F., Franken, A., Wassernaar, M.J.E., Tiemensma, J., Romijn, J.A., Pereira, A.M.
Publikováno v:
ResearcherID
Endocrine Reviews, 31(3)
Endocrine Reviews, 31(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5d31667a9fd692d7aaa60a2262159288
https://hdl.handle.net/1887/106235
https://hdl.handle.net/1887/106235
Autor:
Nieuwlaat, W.A.
Contains fulltext : 26918_recohutha.pdf (Publisher’s version ) (Open Access) RU Radboud Universiteit Nijmegen, 13 mei 2005 Promotores : Hermus, A.R.M.M., Corstens, F.H.M. Co-promotor : Huysmans, D.A.K.C. 209 p.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c74397cdf47f9b4a83c8163d46e65c9f
https://hdl.handle.net/2066/26918
https://hdl.handle.net/2066/26918
Publikováno v:
Journal of Clinical Endocrinology and Metabolism, 86, 5330-6
Journal of Clinical Endocrinology and Metabolism, 86, 11, pp. 5330-6
Journal of Clinical Endocrinology and Metabolism, 86, 11, pp. 5330-6
Item does not contain fulltext In a recent study, we demonstrated that pretreatment with a single, low dose of recombinant human TSH (rhTSH) doubles 24-h thyroid radioactive iodine uptake in patients with nodular goiter. The purpose of the present st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::985145609ef2deb9d6289f705fbe5109
http://hdl.handle.net/2066/188652
http://hdl.handle.net/2066/188652
Autor:
Huysmans, D.a., Nieuwlaat, W.a., Erdtsieck, R.j., Schellekens, A.p., Bus, J.f., Bravenboer, Bert, Hermus, Armm
Radioiodine (I-131) is increasingly used as treatment for volume reduction of nontoxic, nodular goiter. A high dose of I-131 is often needed because of low thyroid radioiodide uptake (RAIU). We investigated whether pretreatment with a single, low dos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3848::49070080e1bb4f7cd33c86601ae68cf1
https://hdl.handle.net/20.500.14017/3c42f2a7-25b3-4800-a33f-503c08b90c7a
https://hdl.handle.net/20.500.14017/3c42f2a7-25b3-4800-a33f-503c08b90c7a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.